|
G
|
Dek
|
DEK proto-oncogene
|
multiple interactions
|
ISO
|
DEK protein results in increased chemical synthesis of and results in increased secretion of Alanine
|
CTD |
PMID:28558019 |
|
NCBI chr17:17,786,989...17,809,096
Ensembl chr17:17,787,139...17,810,122
|
|
G
|
Idh2
|
isocitrate dehydrogenase (NADP(+)) 2
|
decreases abundance multiple interactions
|
ISO
|
IDH2 protein mutant form results in decreased abundance of Alanine Triazines inhibits the reaction [IDH2 protein mutant form results in decreased abundance of Alanine]
|
CTD |
PMID:27469509 |
|
NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:143,439,323...143,467,248
|
|
|
G
|
Gria3
|
glutamate ionotropic receptor AMPA type subunit 3
|
affects response to substance
|
ISO
|
GRIA3 protein affects the susceptibility to 5-fluorowillardiine
|
CTD |
PMID:15264227 |
|
NCBI chr X:125,103,975...125,369,690
Ensembl chr X:125,103,782...125,369,679
|
|
|
G
|
Ctsd
|
cathepsin D
|
multiple interactions
|
EXP
|
alliin affects the reaction [Isoproterenol affects the activity of CTSD protein]
|
CTD |
PMID:17623887 |
|
NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:206,956,944...206,968,821
|
|
G
|
Fasn
|
fatty acid synthase
|
multiple interactions
|
ISO
|
alliin inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of FASN mRNA]; alliin inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of FASN protein]
|
CTD |
PMID:29305303 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,570,413...106,588,583
|
|
G
|
Fgf2
|
fibroblast growth factor 2
|
decreases secretion multiple interactions
|
ISO
|
alliin results in decreased secretion of FGF2 protein alliin promotes the reaction [FGF2 protein results in increased expression of TP53 protein]
|
CTD |
PMID:16351512 |
|
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493
|
|
G
|
Hmgcr
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
multiple interactions
|
EXP ISO
|
alliin inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein] alliin inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of HMGCR mRNA]; alliin inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of HMGCR protein]
|
CTD |
PMID:16640830 PMID:29305303 |
|
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533
|
|
G
|
Lcat
|
lecithin cholesterol acyltransferase
|
multiple interactions
|
EXP
|
alliin inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein]
|
CTD |
PMID:16640830 |
|
NCBI chr19:50,744,598...50,748,064
Ensembl chr19:50,744,601...50,748,081
|
|
G
|
Srebf1
|
sterol regulatory element binding transcription factor 1
|
multiple interactions
|
ISO
|
alliin inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of SREBF1 mRNA]; alliin inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of SREBF1 protein]
|
CTD |
PMID:29305303 |
|
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,507,152...45,529,164
|
|
G
|
Srebf2
|
sterol regulatory element binding transcription factor 2
|
multiple interactions
|
ISO
|
alliin inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of SREBF2 mRNA]; alliin inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of SREBF2 protein]
|
CTD |
PMID:29305303 |
|
NCBI chr 7:115,542,774...115,600,945
Ensembl chr 7:115,543,290...115,600,943
|
|
G
|
Tp53
|
tumor protein p53
|
multiple interactions
|
ISO
|
alliin promotes the reaction [FGF2 protein results in increased expression of TP53 protein]
|
CTD |
PMID:16351512 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
G
|
Vegfa
|
vascular endothelial growth factor A
|
decreases secretion
|
ISO
|
alliin results in decreased secretion of VEGFA protein
|
CTD |
PMID:16351512 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
|
G
|
Alad
|
aminolevulinate dehydratase
|
decreases activity
|
EXP
|
Selenocysteine analog results in decreased activity of ALAD protein
|
CTD |
PMID:14630126 |
|
NCBI chr 5:80,977,562...80,987,901
Ensembl chr 5:80,977,562...80,988,041
|
|
G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions
|
ISO
|
Selenocysteine inhibits the reaction [Lipopolysaccharides affects the localization of and affects the activity of FOS protein]; Selenocysteine inhibits the reaction [Peroxynitrous Acid affects the localization of and affects the activity of FOS protein]
|
CTD |
PMID:14572605 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
G
|
Gsta2
|
glutathione S-transferase alpha 2
|
increases expression
|
EXP
|
Selenocysteine results in increased expression of GSTA2 mRNA
|
CTD |
PMID:12034368 |
|
NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:88,064,616...88,077,092
|
|
G
|
Gsta3
|
glutathione S-transferase alpha 3
|
increases expression
|
EXP
|
Selenocysteine results in increased expression of GSTA3 mRNA
|
CTD |
PMID:12034368 |
|
NCBI chr 9:31,154,989...31,180,653
Ensembl chr 9:31,154,989...31,180,654
|
|
G
|
Gsta5
|
glutathione S-transferase alpha 5
|
increases expression
|
EXP
|
Selenocysteine results in increased expression of GSTA5 mRNA
|
CTD |
PMID:12034368 |
|
NCBI chr 8:87,985,768...87,997,766
Ensembl chr 8:87,985,258...87,997,765
|
|
G
|
Gstp1
|
glutathione S-transferase pi 1
|
increases expression
|
EXP
|
Selenocysteine results in increased expression of GSTP1 mRNA
|
CTD |
PMID:12034368 |
|
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:210,767,237...210,769,705
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO
|
Selenocysteine inhibits the reaction [Lipopolysaccharides affects the localization of and affects the activity of RELA protein]; Selenocysteine inhibits the reaction [Peroxynitrous Acid affects the localization of and affects the activity of RELA protein]
|
CTD |
PMID:14572605 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
|
G
|
Abcb1a
|
ATP binding cassette subfamily B member 1A
|
multiple interactions
|
ISO
|
LCL161 binds to and affects the activity of ABCB1 protein; LCL161 inhibits the reaction [ABCB1 protein results in increased export of Fluorescent Dyes]; LCL161 inhibits the reaction [ABCB1 protein results in increased export of mitotracker green FM]
|
CTD |
PMID:32497533 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
|
|
G
|
Birc2
|
baculoviral IAP repeat-containing 2
|
decreases expression decreases expression
|
ISO
|
LCL161 results in decreased expression of BIRC2 protein LCL161 decreases expression of BIRC2 protein in hepatocellular carcinoma cells
|
CTD RGD |
PMID:32497533 PMID:24976294 |
RGD:153305953 |
NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911
|
|
G
|
Birc3
|
baculoviral IAP repeat-containing 3
|
decreases expression
|
ISO
|
LCL161 decreases expression of BIRC3 protein in hepatocellular carcinoma cells
|
RGD |
PMID:24976294 |
RGD:153305953 |
NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:13,285,703...13,298,590
|
|
G
|
Birc5
|
baculoviral IAP repeat-containing 5
|
decreases expression
|
ISO
|
LCL161 results in decreased expression of BIRC5 protein
|
CTD |
PMID:32497533 |
|
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
|
|
G
|
Xiap
|
X-linked inhibitor of apoptosis
|
decreases expression
|
ISO
|
LCL161 decreases expression of XIAP protein in hepatocellular carcinoma cells
|
RGD |
PMID:24976294 |
RGD:153305953 |
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:125,737,971...125,803,978
|
|
|
G
|
Cyp2c6
|
cytochrome P450, family 2, subfamily C, polypeptide 6
|
decreases expression
|
ISO
|
metalaxyl results in decreased expression of CYP2C19 protein
|
CTD |
PMID:32194361 |
|
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:247,879,078...247,916,798
|
|
G
|
Cyp7a1
|
cytochrome P450 family 7 subfamily A member 1
|
decreases expression
|
ISO
|
metalaxyl results in decreased expression of CYP7A1 protein
|
CTD |
PMID:32194361 |
|
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:24,174,505...24,184,202
|
|
|
G
|
Ncoa2
|
nuclear receptor coactivator 2
|
multiple interactions
|
ISO
|
N-benzoylalanine promotes the reaction [THRA protein binds to NCOA2 protein]; N-benzoylalanine promotes the reaction [THRB protein binds to NCOA2 protein]
|
CTD |
PMID:31566444 |
|
NCBI chr 5:10,618,712...10,852,776
Ensembl chr 5:10,618,722...10,852,776
|
|
G
|
Thra
|
thyroid hormone receptor alpha
|
multiple interactions
|
ISO
|
N-benzoylalanine promotes the reaction [THRA protein binds to NCOA2 protein]
|
CTD |
PMID:31566444 |
|
NCBI chr10:84,198,141...84,225,659
Ensembl chr10:84,197,011...84,225,657
|
|
G
|
Thrb
|
thyroid hormone receptor beta
|
multiple interactions affects binding
|
ISO
|
N-benzoylalanine promotes the reaction [THRB protein binds to NCOA2 protein] N-benzoylalanine binds to THRB protein
|
CTD |
PMID:31566444 |
|
NCBI chr15:10,115,954...10,465,231
Ensembl chr15:10,115,954...10,313,680
|
|
|
G
|
Abcc1
|
ATP binding cassette subfamily C member 1
|
multiple interactions
|
ISO
|
[selenomethylselenocysteine co-treated with irinotecan] results in decreased expression of ABCC1
|
CTD |
PMID:15897249 |
|
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:1,038,947...1,162,404
|
|
G
|
Abcc4
|
ATP binding cassette subfamily C member 4
|
multiple interactions decreases expression
|
EXP
|
Isoflavones promotes the reaction [selenomethylselenocysteine results in decreased expression of ABCC4 mRNA]
|
CTD |
PMID:19025659 |
|
NCBI chr15:101,948,387...102,182,912
Ensembl chr15:101,949,433...102,181,375
|
|
G
|
Apaf1
|
apoptotic peptidase activating factor 1
|
increases expression
|
ISO
|
selenomethylselenocysteine metabolite results in increased expression of APAF1 mRNA
|
CTD |
PMID:25321483 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:27,381,855...27,466,772
|
|
G
|
Ar
|
androgen receptor
|
decreases expression
|
ISO EXP
|
selenomethylselenocysteine results in decreased expression of AR protein selenomethylselenocysteine results in decreased expression of AR mRNA
|
CTD |
PMID:16637076 PMID:19025659 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:67,135,317...67,304,467
|
|
G
|
Bak1
|
BCL2-antagonist/killer 1
|
increases expression
|
ISO
|
selenomethylselenocysteine metabolite results in increased expression of BAK1 mRNA
|
CTD |
PMID:25321483 |
|
NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,102,335...5,110,974
|
|
G
|
Banp
|
Btg3 associated nuclear protein
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of BANP mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr19:66,916,417...66,994,286
Ensembl chr19:66,916,267...66,991,317
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
decreases expression multiple interactions
|
ISO EXP
|
selenomethylselenocysteine results in decreased expression of BCL2 mRNA [selenomethylselenocysteine results in decreased expression of BCL2 mRNA] which results in increased activity of TNFSF10 protein selenomethylselenocysteine results in decreased expression of BCL2 protein
|
CTD |
PMID:11396176 PMID:19360359 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
G
|
Bcl2l1
|
Bcl2-like 1
|
decreases expression
|
ISO
|
selenomethylselenocysteine metabolite results in decreased expression of BCL2L1 mRNA
|
CTD |
PMID:25321483 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
G
|
Bcl2l11
|
Bcl2-like 11
|
increases expression
|
ISO
|
selenomethylselenocysteine metabolite results in increased expression of BCL2L11 mRNA
|
CTD |
PMID:25321483 |
|
NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695
|
|
G
|
Bmal1
|
basic helix-loop-helix ARNT like 1
|
decreases expression
|
EXP
|
selenomethylselenocysteine results in decreased expression of BMAL1 mRNA
|
CTD |
PMID:19122877 |
|
NCBI chr 1:176,766,222...176,864,741
Ensembl chr 1:176,829,305...176,864,739
|
|
G
|
Bmf
|
Bcl2 modifying factor
|
multiple interactions increases expression
|
ISO
|
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [selenomethylselenocysteine metabolite results in increased expression of BMF mRNA]; BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP3 protein modified form]; BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP6 protein modified form]; BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP9 protein modified form]; BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of PARP1 protein modified form]; HDAC8 inhibits the reaction [selenomethylselenocysteine metabolite results in increased expression of BMF mRNA]; selenomethylselenocysteine metabolite inhibits the reaction [HDAC8 protein binds to BMF promoter]; selenomethylselenocysteine metabolite inhibits the reaction [STAT3 protein binds to BMF promoter]; selenomethylselenocysteine metabolite promotes the reaction [EP300 protein binds to BMF promoter]; selenomethylselenocysteine metabolite promotes the reaction [SP3 protein binds to BMF promoter]; STAT3 protein inhibits the reaction [selenomethylselenocysteine metabolite results in increased expression of BMF mRNA] selenomethylselenocysteine metabolite results in increased expression of BMF protein selenomethylselenocysteine metabolite results in increased expression of BMF mRNA; selenomethylselenocysteine metabolite results in increased expression of BMF protein
|
CTD |
PMID:25321483 |
|
NCBI chr 3:125,953,466...125,974,087
Ensembl chr 3:125,953,466...125,974,258
|
|
G
|
Casp3
|
caspase 3
|
increases activity multiple interactions increases expression
|
ISO
|
selenomethylselenocysteine results in increased activity of CASP3 protein BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP3 protein modified form]
|
CTD |
PMID:15318939 PMID:25321483 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp6
|
caspase 6
|
increases expression multiple interactions
|
ISO
|
selenomethylselenocysteine metabolite results in increased expression of CASP6 protein modified form BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP6 protein modified form]
|
CTD |
PMID:25321483 |
|
NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:221,140,256...221,152,726
|
|
G
|
Casp8
|
caspase 8
|
increases expression
|
ISO
|
selenomethylselenocysteine metabolite results in increased expression of CASP8 protein modified form
|
CTD |
PMID:25321483 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
G
|
Casp9
|
caspase 9
|
multiple interactions increases expression
|
ISO
|
BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP9 protein modified form]
|
CTD |
PMID:25321483 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
G
|
Ccna2
|
cyclin A2
|
decreases expression
|
EXP
|
selenomethylselenocysteine results in decreased expression of CCNA2 protein
|
CTD |
PMID:11396176 |
|
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701
|
|
G
|
Ccnd1
|
cyclin D1
|
decreases expression multiple interactions
|
ISO EXP
|
selenomethylselenocysteine results in decreased expression of CCND1 protein selenomethylselenocysteine results in decreased expression of CCND1 mRNA; selenomethylselenocysteine results in decreased expression of CCND1 protein [selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of CCND1 protein
|
CTD |
PMID:11396176 PMID:18855134 PMID:19276161 |
|
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
|
|
G
|
Cdk2
|
cyclin dependent kinase 2
|
multiple interactions
|
ISO
|
selenomethylselenocysteine results in decreased phosphorylation of and results in decreased activity of CDK2 protein
|
CTD |
PMID:10656618 |
|
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878
|
|
G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
increases expression multiple interactions
|
ISO
|
selenomethylselenocysteine metabolite results in increased expression of CDKN1A protein [Aminooxyacetic Acid results in decreased metabolism of selenomethylselenocysteine] which results in decreased expression of CDKN1A protein
|
CTD |
PMID:25321483 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
G
|
Cdkn1b
|
cyclin-dependent kinase inhibitor 1B
|
increases expression
|
EXP
|
selenomethylselenocysteine results in increased expression of CDKN1B protein
|
CTD |
PMID:11396176 PMID:19276161 |
|
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498
|
|
G
|
Ces1d
|
carboxylesterase 1D
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of CES1
|
CTD |
PMID:15897249 |
|
NCBI chr19:30,046,494...30,085,039
Ensembl chr19:30,046,449...30,085,449
|
|
G
|
Chmp1a
|
charged multivesicular body protein 1A
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of CHMP1A mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr19:68,146,672...68,154,952
Ensembl chr19:68,146,672...68,154,952
|
|
G
|
Col1a1
|
collagen type I alpha 1 chain
|
decreases expression
|
ISO
|
selenomethylselenocysteine results in decreased expression of COL1A1 mRNA; selenomethylselenocysteine results in decreased expression of COL1A1 protein
|
CTD |
PMID:18514395 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
|
|
G
|
Col1a2
|
collagen type I alpha 2 chain
|
decreases expression
|
ISO
|
selenomethylselenocysteine results in decreased expression of COL1A2 mRNA; selenomethylselenocysteine results in decreased expression of COL1A2 protein
|
CTD |
PMID:18514395 |
|
NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:33,518,420...33,553,995
|
|
G
|
Col4a5
|
collagen type IV alpha 5 chain
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of COL4A5 mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr X:109,907,251...110,111,214
Ensembl chr X:109,907,346...110,111,214
|
|
G
|
Col6a1
|
collagen type VI alpha 1 chain
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of COL6A1 mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr20:11,905,690...11,924,111
Ensembl chr20:11,905,457...11,924,107
|
|
G
|
Col7a1
|
collagen type VII alpha 1 chain
|
decreases expression
|
ISO
|
selenomethylselenocysteine results in decreased expression of COL7A1 mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr 8:118,483,364...118,515,736
Ensembl chr 8:118,483,364...118,517,439
|
|
G
|
Cry2
|
cryptochrome circadian regulator 2
|
increases expression
|
EXP
|
selenomethylselenocysteine results in increased expression of CRY2 mRNA
|
CTD |
PMID:19122877 |
|
NCBI chr 3:98,830,479...98,860,437
Ensembl chr 3:98,830,483...98,860,447
|
|
G
|
Cyp3a9
|
cytochrome P450, family 3, subfamily a, polypeptide 9
|
multiple interactions
|
ISO
|
[selenomethylselenocysteine co-treated with irinotecan] results in increased expression of CYP3A5
|
CTD |
PMID:15897249 |
|
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154
|
|
G
|
Dbp
|
D-box binding PAR bZIP transcription factor
|
increases expression
|
EXP
|
selenomethylselenocysteine results in increased expression of DBP mRNA
|
CTD |
PMID:19122877 |
|
NCBI chr 1:105,312,256...105,317,205
Ensembl chr 1:105,312,108...105,317,205
|
|
G
|
Ddit3
|
DNA-damage inducible transcript 3
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of DDIT3 mRNA
|
CTD |
PMID:10656618 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
G
|
Dhcr24
|
24-dehydrocholesterol reductase
|
decreases expression
|
EXP
|
selenomethylselenocysteine results in decreased expression of DHCR24 mRNA
|
CTD |
PMID:19025659 |
|
NCBI chr 5:126,573,366...126,599,940
Ensembl chr 5:126,573,338...126,599,936
|
|
G
|
Drg1
|
developmentally regulated GTP binding protein 1
|
multiple interactions
|
ISO
|
[selenomethylselenocysteine co-treated with irinotecan] results in decreased expression of DRG1
|
CTD |
PMID:15897249 |
|
NCBI chr14:82,328,320...82,344,416
Ensembl chr14:82,328,320...82,344,348
|
|
G
|
Ep300
|
E1A binding protein p300
|
multiple interactions
|
ISO
|
selenomethylselenocysteine metabolite promotes the reaction [EP300 protein binds to BMF promoter]
|
CTD |
PMID:25321483 |
|
NCBI chr 7:114,987,857...115,058,652
Ensembl chr 7:114,946,982...115,058,574
|
|
G
|
Esr1
|
estrogen receptor 1
|
decreases expression multiple interactions
|
ISO
|
selenomethylselenocysteine results in decreased expression of ESR1 protein [selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of ESR1 protein
|
CTD |
PMID:18855134 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:43,644,392...43,900,354
|
|
G
|
Faslg
|
Fas ligand
|
multiple interactions
|
ISO
|
[selenomethylselenocysteine co-treated with irinotecan] results in increased expression of FASLG
|
CTD |
PMID:15897249 |
|
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
|
|
G
|
Gadd45a
|
growth arrest and DNA-damage-inducible, alpha
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of GADD45A mRNA
|
CTD |
PMID:10656618 |
|
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:97,484,502...97,486,807
|
|
G
|
Gpx1
|
glutathione peroxidase 1
|
increases activity increases expression
|
ISO
|
selenomethylselenocysteine results in increased activity of GPX1 protein selenomethylselenocysteine results in increased expression of GPX1 mRNA; selenomethylselenocysteine results in increased expression of GPX1 protein
|
CTD |
PMID:18514395 PMID:19033020 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
G
|
Gpx4
|
glutathione peroxidase 4
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of GPX4 mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629
|
|
G
|
Grik1
|
glutamate ionotropic receptor kainate type subunit 1
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of GRIK1 mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr11:40,655,974...41,056,966
Ensembl chr11:40,655,975...41,056,517
|
|
G
|
Grik3
|
glutamate ionotropic receptor kainate type subunit 3
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of GRIK3 mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr 5:143,052,442...143,268,873
Ensembl chr 5:143,052,442...143,268,873
|
|
G
|
Hdac8
|
histone deacetylase 8
|
multiple interactions
|
ISO
|
HDAC8 inhibits the reaction [selenomethylselenocysteine metabolite results in increased expression of BMF mRNA]; selenomethylselenocysteine metabolite inhibits the reaction [HDAC8 protein binds to BMF promoter]
|
CTD |
PMID:25321483 |
|
NCBI chr X:71,425,240...71,632,865
Ensembl chr X:71,394,928...71,632,865
|
|
G
|
Igf1r
|
insulin-like growth factor 1 receptor
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of IGF1R mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:130,959,997...131,248,664
|
|
G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
increases phosphorylation
|
EXP
|
selenomethylselenocysteine results in increased phosphorylation of JUN protein
|
CTD |
PMID:19276161 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
G
|
Klk1
|
kallikrein 1
|
decreases expression
|
ISO
|
selenomethylselenocysteine results in decreased expression of KLK3 protein
|
CTD |
PMID:16637076 |
|
NCBI chr 1:103,779,152...103,783,270
Ensembl chr 1:103,779,164...103,783,270
|
|
G
|
Mki67
|
marker of proliferation Ki-67
|
multiple interactions decreases expression
|
ISO
|
[selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of MKI67 protein selenomethylselenocysteine results in decreased expression of MKI67 protein
|
CTD |
PMID:18855134 |
|
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593
|
|
G
|
Msrb1
|
methionine sulfoxide reductase B1
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of MSRB1 mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr10:14,269,414...14,275,140
Ensembl chr10:14,269,414...14,274,184
|
|
G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
multiple interactions
|
ISO
|
selenomethylselenocysteine inhibits the reaction [Lipopolysaccharides results in increased localization of NFKB1 protein]
|
CTD |
PMID:21213327 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions
|
ISO
|
selenomethylselenocysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; selenomethylselenocysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
|
CTD |
PMID:21213327 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
G
|
P4ha1
|
prolyl 4-hydroxylase subunit alpha 1
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of P4HA1 mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr20:27,784,696...27,895,785
Ensembl chr20:27,845,141...27,895,404
|
|
G
|
Parp1
|
poly (ADP-ribose) polymerase 1
|
multiple interactions increases expression
|
ISO
|
[Aminooxyacetic Acid results in decreased metabolism of selenomethylselenocysteine] which results in decreased expression of PARP1 protein modified form; BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of PARP1 protein modified form]
|
CTD |
PMID:25321483 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:94,839,433...94,871,567
|
|
G
|
Per2
|
period circadian regulator 2
|
increases expression
|
EXP
|
selenomethylselenocysteine results in increased expression of PER2 mRNA
|
CTD |
PMID:19122877 |
|
NCBI chr 9:99,454,828...99,497,069
Ensembl chr 9:99,454,830...99,496,993
|
|
G
|
Per3
|
period circadian regulator 3
|
increases expression
|
EXP
|
selenomethylselenocysteine results in increased expression of PER3 mRNA
|
CTD |
PMID:19122877 |
|
NCBI chr 5:166,740,914...166,778,243
Ensembl chr 5:166,743,050...166,777,999
|
|
G
|
Pgr
|
progesterone receptor
|
decreases expression multiple interactions
|
ISO
|
selenomethylselenocysteine results in decreased expression of PGR protein [selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of PGR protein
|
CTD |
PMID:18855134 |
|
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:14,354,398...14,413,271
|
|
G
|
Ppp1r15a
|
protein phosphatase 1, regulatory subunit 15A
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of PPP1R15A mRNA
|
CTD |
PMID:10656618 |
|
NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:105,136,525...105,139,774
|
|
G
|
Prkce
|
protein kinase C, epsilon
|
decreases expression
|
ISO
|
selenomethylselenocysteine results in decreased expression of PRKCE protein
|
CTD |
PMID:10656618 |
|
NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:13,718,050...14,204,288
|
|
G
|
Prkcz
|
protein kinase C, zeta
|
decreases expression
|
ISO
|
selenomethylselenocysteine results in decreased expression of PRKCZ protein
|
CTD |
PMID:10656618 |
|
NCBI chr 5:171,101,774...171,212,694
Ensembl chr 5:171,101,774...171,212,674
|
|
G
|
Rab3b
|
RAB3B, member RAS oncogene family
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of RAB3B mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr 5:128,859,034...128,926,087
Ensembl chr 5:128,841,716...128,926,086
|
|
G
|
Rab4a
|
RAB4A, member RAS oncogene family
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of RAB4A mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr19:68,692,228...68,720,169
Ensembl chr19:68,692,890...68,720,166
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO
|
selenomethylselenocysteine inhibits the reaction [Lipopolysaccharides results in increased localization of RELA protein]
|
CTD |
PMID:21213327 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
G
|
Scarb1
|
scavenger receptor class B, member 1
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of SCARB1 mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr12:36,957,302...37,023,982
Ensembl chr12:36,957,496...37,023,980
|
|
G
|
Selenof
|
selenoprotein F
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of SELENOF mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr 2:236,302,439...236,335,216
Ensembl chr 2:236,302,683...236,335,210
|
|
G
|
Selenop
|
selenoprotein P
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of SELENOP mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr 2:54,225,736...54,236,022
Ensembl chr 2:54,225,152...54,236,019
|
|
G
|
Selenow
|
selenoprotein W
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of SELENOW mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr 1:85,727,631...85,732,703
Ensembl chr 1:85,727,632...85,732,703
|
|
G
|
Slc3a1
|
solute carrier family 3 member 1
|
increases uptake
|
ISO
|
SLC3A1 protein results in increased uptake of selenomethylselenocysteine
|
CTD |
PMID:18845132 |
|
NCBI chr 6:15,361,037...15,396,695
Ensembl chr 6:15,361,046...15,394,775
|
|
G
|
Slc6a19
|
solute carrier family 6 member 19
|
increases uptake
|
ISO
|
SLC6A19 protein results in increased uptake of selenomethylselenocysteine
|
CTD |
PMID:18845132 |
|
NCBI chr 1:31,414,744...31,434,932
Ensembl chr 1:31,414,744...31,433,517
|
|
G
|
Slc6a20a
|
solute carrier family 6 member 20a
|
increases uptake
|
ISO
|
SLC6A20B protein results in increased uptake of selenomethylselenocysteine
|
CTD |
PMID:18845132 |
|
NCBI chr 8:132,159,768...132,200,016
Ensembl chr 8:132,158,915...132,200,008
|
|
G
|
Snap23
|
synaptosome associated protein 23
|
decreases expression
|
ISO
|
selenomethylselenocysteine results in decreased expression of SNAP23 mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr 3:127,966,184...127,999,929
Ensembl chr 3:127,967,886...127,998,067
|
|
G
|
Sort1
|
sortilin 1
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of SORT1 mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr 2:198,609,466...198,690,481
Ensembl chr 2:198,612,148...198,690,481
|
|
G
|
Sp3
|
Sp3 transcription factor
|
multiple interactions
|
ISO
|
selenomethylselenocysteine metabolite promotes the reaction [SP3 protein binds to BMF promoter]
|
CTD |
PMID:25321483 |
|
NCBI chr 3:78,219,421...78,272,318
Ensembl chr 3:78,219,426...78,264,517
|
|
G
|
Spp1
|
secreted phosphoprotein 1
|
decreases expression
|
ISO
|
selenomethylselenocysteine results in decreased expression of SPP1 protein
|
CTD |
PMID:15318939 |
|
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820
|
|
G
|
Srd5a1
|
steroid 5 alpha-reductase 1
|
multiple interactions
|
EXP
|
[selenomethylselenocysteine co-treated with Isoflavones] results in decreased activity of SRD5A1 protein
|
CTD |
PMID:19025659 |
|
NCBI chr 1:35,514,914...35,548,898
Ensembl chr 1:35,514,846...35,548,903
|
|
G
|
Stat3
|
signal transducer and activator of transcription 3
|
multiple interactions
|
ISO
|
selenomethylselenocysteine metabolite inhibits the reaction [STAT3 protein binds to BMF promoter]; STAT3 protein inhibits the reaction [selenomethylselenocysteine metabolite results in increased expression of BMF mRNA]
|
CTD |
PMID:25321483 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
G
|
Stx3
|
syntaxin 3
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of STX3 mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr 1:217,940,697...218,114,865
Ensembl chr 1:217,909,169...218,110,466
|
|
G
|
Tnfsf10
|
TNF superfamily member 10
|
multiple interactions
|
ISO
|
[selenomethylselenocysteine results in decreased expression of BCL2 mRNA] which results in increased activity of TNFSF10 protein
|
CTD |
PMID:19360359 |
|
NCBI chr 2:112,136,550...112,155,903
|
|
G
|
Trnau1ap
|
tRNA selenocysteine 1 associated protein 1
|
increases expression
|
ISO
|
selenomethylselenocysteine results in increased expression of TRNAU1AP mRNA
|
CTD |
PMID:18514395 |
|
NCBI chr 5:149,791,631...149,808,149
Ensembl chr 5:149,791,631...149,808,680
|
|
G
|
Xpa
|
XPA, DNA damage recognition and repair factor
|
multiple interactions
|
ISO
|
selenomethylselenocysteine inhibits the reaction [Zinc binds to XPA protein]
|
CTD |
PMID:15265038 |
|
NCBI chr 5:65,227,281...65,275,784
Ensembl chr 5:65,227,281...65,272,425
|
|
|
G
|
Klrc1
|
killer cell lectin like receptor C1
|
decreases expression
|
ISO
|
sofosbuvir co-treated with ledipasvir decreased expression of NCR1 protein in natural killer cells
|
RGD |
PMID:31218578 |
RGD:40400920 |
NCBI chr 4:164,828,163...164,838,446
Ensembl chr 4:164,828,163...164,838,464
|
|
G
|
Ncr1
|
natural cytotoxicity triggering receptor 1
|
affects expression
|
ISO
|
sofosbuvir co-treated with ledipasvir affects expression of NCR1 protein in natural killer cells
|
RGD |
PMID:31218578 |
RGD:40400920 |
NCBI chr 1:78,657,409...78,665,255
Ensembl chr 1:78,659,262...78,703,273
|
|